Andrew Reardon, CLO & Secretary: Ligand Pharmaceuticals LGND Sell · Filed 25/06/24

Trade details

Type: Insider sale
Amount: $57,040
Shares · price: 500 sh · $114.08 a share
Held after: 31,903 sh
Stock: Ligand Pharmaceuticals LGND
Person: Andrew ReardonCLO & Secretary
Trade date: 25/06/23
Filed: 25/06/24
Days to filing: 1 days

Sold 1.5% of holdings

Share of holding sold: 1.5%

Ligand Pharmaceuticals trades, last 26 weeks

What else happened in Ligand Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/05/24~25/07/23

Andrew Reardon's recent trades

Andrew ReardonCLO & Secretary
Planned sale10b5-1 planLigand Pharmaceuticals
Planned sale10b5-1 plan
Ligand Pharmaceuticals
LGND
$4.3M
15,000 sh
$4.3M
Filed 09/03
Traded 09/03
Andrew ReardonCLO & Secretary
Planned sale10b5-1 planLigand Pharmaceuticals
Planned sale10b5-1 plan
Ligand Pharmaceuticals
LGND
$3.2M
10,000 sh
$3.2M
Filed 07/01
Traded 07/01
Andrew ReardonCLO & Secretary
Sell10b5-1 planLigand Pharmaceuticals
Sell10b5-1 plan
Ligand Pharmaceuticals
LGND
$323.6K
1,432 sh
$323.6K
Filed 06/02
Traded 06/01
Andrew ReardonCLO & Secretary
Sell10b5-1 planLigand Pharmaceuticals
Sell10b5-1 plan
Ligand Pharmaceuticals
LGND
$279K
1,216 sh
$279K
Filed 06/02
Traded 06/01
Andrew ReardonCLO & Secretary
Sell10b5-1 planLigand Pharmaceuticals
Sell10b5-1 plan
Ligand Pharmaceuticals
LGND
$152.5K
677 sh
$152.5K
Filed 06/02
Traded 06/01